{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T17:30:16Z","timestamp":1792949416742,"version":"4.5.0"},"reference-count":32,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,3,21]],"date-time":"2005-03-21T00:00:00Z","timestamp":1111363200000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2005,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\n\t\t\t\t\t<\/jats:bold> Nasal polyposis (NP) is a chronic inflammatory disorder of the upper respiratory tract, which is often coexist with asthma. However, the pathogenesis of especially in patients with NP is still a matter of debate.<\/jats:p><jats:p><jats:bold>Objective\n\t\t\t\t\t<\/jats:bold> To better understand the immunopathologic mechanism involved in this relationship, we investigated the inflammatory cell profiles in bronchial and nasal tissues of patients with NP alone and with concomitant asthma.<\/jats:p><jats:p><jats:bold>Methods\n\t\t\t\t\t<\/jats:bold> Seventeen patients with NP (six male, 11 female, age range: 19\u201363, mean age: 38.29\u00b113.27 years) were selected for the study. Subjects were divided into two groups based on the presence of asthma or bronchial hyper\u2010responsiveness (BHR). NP without BHR (Group 1) (<jats:italic>n<\/jats:italic>=8), NP and asthma or BHR (Group 2) (<jats:italic>n<\/jats:italic>=9). All patients underwent atopy evaluation including detailed history, skin prick test (SPT), total and specific IgE determination in sera. None of the subjects had taken inhaled, nasal or oral corticosteroids for at least 1 month before the study. Respiratory symptoms of asthmatic patients were controlled with only short acting \u03b2<jats:sub>2<\/jats:sub>\u2010agonist inhaler drugs as needed. NP tissue, nasal and bronchial mucosa biopsies were taken from all patients using fiberoptic endoscopy. CD3, CD8, CD16, CD68, AA1 (mast cell tryptase), human leucocyte antigen\u2010DR (HLA\u2010DR) and eosinophil peroxidase (EPO) expressing cells in specimens were determined by immunohistochemical methods. Positively staining inflammatory cell types were counted. Subepithelial lamina propria and periglandular areas were separately evaluated.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> No significant difference was found in polyp tissue, nasal and bronchial CD3<jats:sup>+<\/jats:sup>, CD8<jats:sup>+<\/jats:sup>, CD16<jats:sup>+<\/jats:sup>, CD68<jats:sup>+<\/jats:sup>, AA1<jats:sup>+<\/jats:sup>, HLA\u2010DR<jats:sup>+<\/jats:sup> and EPO<jats:sup>+<\/jats:sup> positive cells between groups. There were significantly higher numbers of CD8<jats:sup>+<\/jats:sup>, CD16<jats:sup>+<\/jats:sup>, HLA\u2010DR<jats:sup>+<\/jats:sup>, EPO<jats:sup>+<\/jats:sup> cells in the polyp tissue and nasal mucosa vs. the bronchial mucosa in all groups (<jats:italic>P<\/jats:italic>&lt;0.05). However, CD8<jats:sup>+<\/jats:sup> cells were significantly increased in the polyp tissue and bronchial mucosa of patients with NP alone when compared with the patients with both asthma and NP (<jats:italic>P<\/jats:italic>&lt;0.05). CD3<jats:sup>+<\/jats:sup>, CD68<jats:sup>+<\/jats:sup> and CD16<jats:sup>+<\/jats:sup> cell counts were tended to be higher within the nasal polyp tissue of patients with isolated NP compared with counts within nasal and bronchial mucosa of patients with NP and asthma. Also, patients with isolated NP showed more HLA\u2010DR<jats:sup>+<\/jats:sup> cells in the nasal polyp tissue and nasal mucosa than those of patients with NP and asthma. Immunoreactivity for EPO<jats:sup>+<\/jats:sup> eosinophils within the nasal and bronchial mucosa was more prominent in patients with NP and asthma compared with patients with NP alone. The number of EPO<jats:sup>+<\/jats:sup> eosinophils within the polyp tissue, nasal and bronchial mucosa was higher in the skin prick test negative (SPT \u2212ve) group than the SPT positive (SPT +ve) ones.<\/jats:p><jats:p><jats:bold>Conclusions\n\t\t\t\t\t<\/jats:bold> Our results demonstrate that infiltration of inflammatory cells in the nasal and the lower airways do not remarkably differ between patients with NP alone who has no evidence of BHR and asthmatic patients with NP. However, patients with SPT\u2212ve NP reveal more intense eosinophilic inflammation in the entire respiratory mucosa.<\/jats:p>","DOI":"10.1111\/j.1365-2222.2005.02194.x","type":"journal-article","created":{"date-parts":[[2005,3,21]],"date-time":"2005-03-21T22:25:09Z","timestamp":1111443909000},"page":"319-326","source":"Crossref","is-referenced-by-count":37,"title":["Airway inflammation in nasal polyposis: immunopathological aspects of relation to asthma"],"prefix":"10.1111","volume":"35","author":[{"given":"D.","family":"Ediger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. A.","family":"Sin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Heper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Anadolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"M\u03b9s\u03b9rl\u03b9gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,3,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(05)80142-3"},{"key":"e_1_2_6_3_2","first-page":"1421","volume-title":"Middleton's allergy principles & practice","author":"Bachert C","year":"2003"},{"key":"e_1_2_6_4_2","first-page":"76","article-title":"Relationship of nasal disease and sinusitis to bronchial asthma","volume":"49","author":"Slavin RG.","year":"1982","journal-title":"Ann Allergy"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.2500\/108854196778662255"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0007-0971(77)90071-7"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(62)80320-0"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.155.1.9001296"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70118-1"},{"key":"e_1_2_6_10_2","first-page":"1171","article-title":"Rhinitis and asthma","volume":"111","author":"Togias A.","year":"2003","journal-title":"evidence for respiratory system integration"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0105-4538.2003.00354.x"},{"issue":"22","key":"e_1_2_6_12_2","first-page":"p075","article-title":"Nasal polyposis without asthma. Long\u2010term clinical and functional follow\u2010up","volume":"12","author":"Marin JM","year":"1998","journal-title":"Eur Respir J"},{"key":"e_1_2_6_13_2","unstructured":"Global Initiative for Asthma.Guidelines for the diagnosis and management of asthma; highlights of the expert panel report 2. NIH publication no: 97\u20104051A 1997."},{"key":"e_1_2_6_14_2","first-page":"51","volume-title":"Asthma: its pathology and treatment","author":"Cockroft DW","year":"1991"},{"key":"e_1_2_6_15_2","first-page":"183","article-title":"Staging in rhinosinusitis","volume":"31","author":"Lund VJ","year":"1993","journal-title":"Rhinology"},{"key":"e_1_2_6_16_2","first-page":"78","volume-title":"Nasal polyposis. An inflammatory disease and its treatment","author":"Denburg JA.","year":"1997"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1998.tb03767.x"},{"key":"e_1_2_6_18_2","first-page":"508","article-title":"Immunopathology of nasal polyps","volume":"63","author":"Larocca LM","year":"1989","journal-title":"an immunohistochemical approach"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(91)90004-8"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(98)70333-1"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2002.13508.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2001.01193.x"},{"key":"e_1_2_6_23_2","first-page":"19","article-title":"Lymphocyte subsets and antigen\u2010specific IgE antibody in nasal polyps","volume":"72","author":"Liu C\u2010M","year":"1994","journal-title":"Ann Allergy"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612023393738"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62815-3"},{"key":"e_1_2_6_26_2","first-page":"669","article-title":"Nasal polyposis","volume":"54","author":"Kramer MF","year":"1999","journal-title":"eosinophils and interleukin-5"},{"key":"e_1_2_6_27_2","first-page":"616","article-title":"Eosinophils in nasal polyps and nasal mucosa","volume":"91","author":"Stoop AE","year":"1993","journal-title":"an immunohistochemical study"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.15.4.8879177"},{"key":"e_1_2_6_29_2","volume-title":"The nose and lung diseases","author":"Nutku E"},{"key":"e_1_2_6_30_2","first-page":"877","article-title":"Features of airway remodelling and eosinophilic inflammation in chronic rhinosinusitis","volume":"112","author":"Ponikau JU","year":"2003","journal-title":"Is the histopathology similar to asthma?"},{"issue":"29","key":"e_1_2_6_31_2","first-page":"p176","article-title":"Immunoreactivity for IL\u20105, IL\u20103 and GM\u2010CSF in bronchial mucosa from patients with nasal polyposis","volume":"12","author":"Lamblin C","year":"1998","journal-title":"Eur Respir J"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2003.00105.x"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.122458"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2222.2005.02194.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2222.2005.02194.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T22:50:23Z","timestamp":1697237423000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2222.2005.02194.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1111\/j.1365-2222.2005.02194.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2222.2005.02194.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}